Wide Ranks

BFRIW

Biofrontera Inc. Warrants

0.0789

Top Statistics
Market Cap 0.0000 Forward PE 0.0000 Revenue Growth 34.00 %
Current Ratio 1.89 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -38.34 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins -38.34 % Operating Margins -64.69 %
Balance Sheet
Total Cash 4 M Total Cash Per Share 0.7920 Total Debt 1 M
Total Debt To Equity 13.20 Current Ratio 1.89 Book Value Per Share 3.16
All Measures
Message Board Id finmb_531568773 Return On Equity -1.49 City Woburn
Uuid 29bc3b3b-4adc-39a3-be53-3b36e211a9b2 Previous Close 0.1000 Book Value 3.16
Beta 0.5090 Total Debt 1 M Volume 1215
Price To Book 0.0250 Fifty Two Week Low 0.0789 Total Cash Per Share 0.7920
Total Revenue 35 M Max Age 86400 Sand P52 Week Change 0.3133
Operating Margins -64.69 % Net Income To Common -13510000 Trailing Peg Ratio None
Total Cash 4 M Revenue Per Share 11.57 Ebitda Margins -51.97 %
Trailing PE 0.0000 Regular Market Previous Close 0.1000 Target Low Price 0.0000
Gmt Off Set Milliseconds -18000000 Open 0.0839 Free Cashflow -17964750
State MA Dividend Yield 0.00 % Return On Assets -0.4024
Time Zone Short Name EST Trailing Eps -1.30 Day Low 0.0789
Address1 120 Presidential Way Target High Price 0.0000 Price Hint 4
Website https://www.biofrontera-us.com Forward Eps 0.0000 Recommendation Key none
Compensation As Of Epoch Date 1 B Quick Ratio 85.20 % Is_sp_500 False
Regular Market Day High 0.0839 Profit Margins -38.34 % Debt To Equity 13.20
Fifty Two Week High 0.0839 Day High 0.0839 Regular Market Open 0.0839
Industry Key drug-manufacturers-specialty-generic Earnings Growth 0.00 % Revenue Growth 34.00 %
Operating Cashflow -18915000 Currency USD Time Zone Full Name America/New_York
Is_nasdaq_100 False Market Cap 0.0000 Zip 01801
Quote Type EQUITY Industry Drug Manufacturers - Specialty & Generic Long Name Biofrontera Inc.
Regular Market Day Low 0.0789 Current Price 0.0789 Address2 Suite 330
Financial Currency USD Current Ratio 1.89 Gross Margins 47.74 %
Industry Disp Drug Manufacturers - Specialty & Generic Country United States Float Shares 2 M
Forward PE 0.0000 Regular Market Volume 1215 Ebitda -18316000
Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp.

The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo.

The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.